nad has been researched along with Necrotizing Enterocolitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Deng, C; Deng, Q; Ding, X; Guo, C; Liu, Q; Qiu, L; Tian, B; Ye, C; Zhang, X; Zhang, Y | 1 |
| Chen, B; Chen, G; Ding, X; Gao, K; Guo, C; Guo, H; Liu, Q; Mo, D; Xia, B; Ye, C | 1 |
2 other study(ies) available for nad and Necrotizing Enterocolitis
| Article | Year |
|---|---|
Nicotinamide riboside relieves the severity of experimental necrotizing enterocolitis by regulating endothelial function via eNOS deacetylation.
Topics: Animals; Disease Models, Animal; Endothelial Cells; Enterocolitis, Necrotizing; Mice; Microcirculation; NAD; Niacinamide; Nitric Oxide Synthase Type III; Pyridinium Compounds; Sirtuin 1; Tumor Necrosis Factor-alpha | 2022 |
NAMPT inhibition relieves intestinal inflammation by regulating macrophage activation in experimental necrotizing enterocolitis.
Topics: Cytokines; Enterocolitis, Necrotizing; Humans; Infant, Newborn; Inflammation; Macrophage Activation; Macrophages; NAD | 2023 |